PathGroup
Cost of implementation, interoperability challenges, and lagging reimbursement can often outweigh the benefits of transitioning a lab to digital pathology.
NIH Awards $129M to Nine Dx Firms for Rapid COVID-19 Diagnostics
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.
PathGroup Acquires Pathologists Bio-Medical Laboratories
According to PathGroup, the deal will broaden its testing menu and adds more than 120 pathologists covering all pathology sub-specialties to the company.
PGDx, PathGroup to Co-Develop Genomic Profiling Assay
The firms will partner on studies needed to support and secure US regulatory approval for the Elio tissue complete assay.